St Andrews-based investment firm Eos Advisory’s portfolio has reached a total valuation of GBP121 million based on latest investment rounds, and its first two exit events in 2021, including when Genus Plc acquired a large stake in aquaculture specialist Xelect.
In January 2021, Eos announced that it had led a GB{1.24 million investment into RAB-Microfluidics, an Aberdeen-headquartered R&D company developing cutting-edge microfluidic technology to diagnose engine and turbine wear in real time. Founded by CEO Rotimi Alabi, RAB-Microfluidics has since grown the team and gained significant sales.
In February 2021, Eos secured its first strategic investment partnership with US-based Kineticos Life Sciences, to co-invest in early stage Scottish companies. The venture partnership aims to invest over £10 million over the next five years in oncology-focused life sciences ventures.
In June, sustainable food protein scale-up Enough (previously called 3F BIO), a University of Strathclyde spin-out, secured a $43 million Series B round, one of the largest investment rounds into a Scottish technology company to date.
In July, RNA and DNA genetic sequencing specialist Wobble Genomics, a spin-out from the University of Edinburgh’s Roslin Institute and founded by CEO Richard Kuo, secured a GBP2.15 million round led by Eos.
